Information Provided By:
Fly News Breaks for August 6, 2018
AMRN
Aug 6, 2018 | 07:24 EDT
Cantor Fitzgerald analyst Louise Chen views the risk/reward for Amarin shares as favorable ahead of what she expects will be positive results for its Reduce-It outcomes study. Positive results from the study, which are expected by the end of Q3, should drive upward earnings revisions to levels not reflected in consensus numbers and the stock higher, Chen tells investors in a research note. The Street thinks Reduce-It will fail, the analyst adds. She affirms an Overweight rating on Amarin with a $10 price target.
News For AMRN From the Last 2 Days
There are no results for your query AMRN